Ultrasound within 12 minutes may predict cardiac arrest outcomes
NCT ID NCT03494153
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 346 adults who had a cardiac arrest outside the hospital. Doctors used an ultrasound within the first 12 minutes of CPR to see if a still heart (no movement) meant the heart would not restart. The goal was to help decide on next steps like ECMO or organ donation. The study did not test a treatment, but aimed to improve understanding and decision-making.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
346 people
The number who actually took part.
- Started
-
Jan 2019
- Finished
-
Jan 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All adult patients receiving resuscitation by the SMUR team in an CRA are eligible
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult (\>18yo) presenting extra-hospital CRA. Exclusion Criteria: * Resuscitation refusal.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiorespiratory arrest are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CH Saint-Nazaire
Saint-Nazaire, 44600, France
-
Ch Chateaubriant
Châteaubriant, 44036, France
-
Chd Vendee
La Roche-sur-Yon, 85000, France
-
Chru Brest
Brest, 29609, France
-
Chru Tours
Tours, 37000, France
-
Chu Angers
Angers, 49000, France
-
Nantes University Hospital
Nantes, 44093, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.